Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study

Added 258 days ago (04.01.2021)
Authors: Zhang, L., Meng, L., Liu, B., Zhang, Y., Zhu, H., Cui, J., Sun, A., Hu, Y., Jin, J., Jiang, H., Zhang, X., Li, Y., Liu, L., Zhang, W., Liu, X., Gu, J., Qiao, J., Ouyang, G., Liu, X., Luo, J., Jiang, M., Xie, X., Li, J., Zhao, C., Zhang, M., Yang, T., Wang, J.
Read article